Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
Conditions
- Neoplasms
- Neoplasms, Glandular and Epithelial
- Neoplasms by Histologic Type
- Bronchial Neoplasms
- Lung Neoplasms
- Respiratory Tract Neoplasms
- Thoracic Neoplasms
- Digestive System Neoplasms
- Endocrine Gland Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Lung Diseases
- Breast Diseases
- Renal Neoplasm
- Solid Tumors
Interventions
- DRUG: Entinostat
- DRUG: Pembrolizumab
Sponsor
Syndax Pharmaceuticals
Collaborators